Author

Nguyen H. Tran

Institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Observed institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Minnesota)

OpenAlex ID: A5128660436

A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms

2026 · T. R. Jeffry Evans, Natalie Cook, et al. · British Journal of Cancer · 1

Pemigatinib for untreated unresectable/metastatic cholangiocarcinoma (mCCA) with fibroblast growth factor receptor-2 (FGFR2) rearrangement: Phase 3 FIGHT-302 results.

2026 · Tanios S. Bekaii-Saab, Davide Melisi, et al. · Journal of Clinical Oncology · 1

Real-world comparison of atezolizumab/bevacizumab vs durvalumab/tremelimumab in decompensated hepatocellular carcinoma.

2026 · Yu-Han Chen, Wee Han Ng, et al. · Journal of Clinical Oncology

AXIN1 Mutated Hepatocellular Carcinoma

2026 · Michael Torbenson, Chantal E. McCabe, et al. · The American Journal of Surgical Pathology

Works count: 4

Citation count: 2

H-index: 1

I10-index: